Kenvue India presents report on ‘The Hydration Gap for Non-Diarrheal Illnesses’
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
LG Chem will receive totaling up to $95.5 million for the China rights
Subscribe To Our Newsletter & Stay Updated